Exact Mass: 570.3377
Exact Mass Matches: 570.3377
Found 441 metabolites which its exact mass value is equals to given mass value 570.3377
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pyrrhoxanthinol
Pyrrhoxanthinol is found in mollusks. Pyrrhoxanthinol is a constituent of Mytilus edulis (blue mussel) Constituent of Mytilus edulis (blue mussel). Pyrrhoxanthinol is found in mollusks.
Ganoderic acid Mk
Ganoderic acid Q is found in mushrooms. Ganoderic acid Q is a constituent of the cultured mycelium of Ganoderma lucidum (reishi)
Ganodermic acid P2
Ganoderic acid P is found in mushrooms. Ganoderic acid P is a constituent of the cultured mycelium of Ganoderma lucidum (reishi).
3alpha,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11),24-trien-26-oic acid
3beta,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11)24-trien-26-oic acid is found in mushrooms. 3beta,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11)24-trien-26-oic acid is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). 3alpha,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11),24-trien-26-oic acid is found in mushrooms.
carbenoxolone
DG(8:0/6 keto-PGF1alpha/0:0)
DG(8:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(6 keto-PGF1alpha/8:0/0:0)
DG(6 keto-PGF1alpha/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/6 keto-PGF1alpha)
DG(8:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(6 keto-PGF1alpha/0:0/8:0)
DG(6 keto-PGF1alpha/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/TXB2/0:0)
DG(8:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(TXB2/8:0/0:0)
DG(TXB2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/TXB2)
DG(8:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(TXB2/0:0/8:0)
DG(TXB2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Pyrrhoxanthinol 5,8-furanoxide
3alpha-Carboxyacetoxy-24-methylene-23-oxolanost-8-en-26-oic acid
15alpha,22S-Diacetoxy-3beta-hydroxylanosta-7,9(11),24E-trien-26-oic acid
3-[(Z)-5-[6-hydroxy-5,5,8a-trimethyl-2-methylidene-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-3-oxopropanoic acid
1-benzoyl-11-(3,7-dimethylocta-2,6-dienyl)-6,6,13,13-tetramethyl-5-(1-methylethyl)tetracyclo[7.3.1.1(3,11).0(3,7)]tetradecane-2,12,14-trione|hypersampsone G
3-[hydroxy(phenyl)methylene]-6-methyl-1,5,7-tris(3-methyl-2-buten-1-yl)-6-(4-methyl-3-penten-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
(-)-(R)-8-(3S,9S,14aR)-9-benzyl-6,6-dimethyl-1,4,7,10-tetraoxotetradecahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecin-3-yl-3-oxooctan-2-yl acetate
(e)-5,6-dihydroxy-3-(3-hydroxy-5-oxo-4-undecylfuran-2(5h)-ylidene)-7-undecylbenzofuran-2(3h)-one
13-benzoyl-6,6,8,14,14-pentamethyl-11,15-di(3-methyl-2-butenyl)-9-oxatetracyclo[11.3.1.01,10.03,8]heptadec-10-ene-12,17-dione
2,3-Di-Ac-(2alpha,3beta,18beta)-2,3,18-Trihydroxy-5,12-oleanadien-28-oic acid
(8R)-5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-[(2R,3R)-3-methyl-3-(4-methylpen-3-ten-1-yl)oxiranyl]tricyclo[3.3.1.13,7]decane-2,4,9-trione|hyperandrone A
(11R*)-1-benzoyl-6,6,12,12-tetramethyl-9-(3,7-dimethylocta-2,6-dienyl)-11-(3-methyl-2-butenyl)-7-oxatricyclo[7.3.1.0(3,8)]trideca-3(8)-ene-2,13-dione|hypersampsone K
11(12)-Benzoyl,12(11)-(3-methylbatanoyl)-3,8,11,12,14-Pentahydroxypregnan-20-one
4-Acetoxy-2,3-epoxy-5,8,10-tris(2-methylpropanoyloxy)-7(14)-bisabolene-1,11-diol
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based on: CCMSLIB00000845831]
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based: Match]
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based on: CCMSLIB00000845834]
Pyrrhoxanthinol
Window width to select the precursor ion was 3 Da.; CONE_VOLTAGE was 20 V.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
3-[(Z)-5-[6-hydroxy-5,5,8a-trimethyl-2-methylidene-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-3-oxopropanoic acid_major
Carbenoxolone
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C471 - Enzyme Inhibitor > C54678 - Hydroxysteroid Dehydrogenase Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
His Lys Met Arg
His Lys Arg Met
His Lys Thr Trp
His Lys Trp Thr
His Met Lys Arg
His Met Arg Lys
His Arg Lys Met
His Arg Met Lys
His Thr Lys Trp
His Thr Trp Lys
His Trp Lys Thr
His Trp Thr Lys
Ile Ile Tyr Tyr
Ile Leu Tyr Tyr
Ile Pro Arg Trp
Ile Pro Trp Arg
Ile Arg Pro Trp
Ile Arg Trp Pro
Ile Trp Pro Arg
Ile Trp Arg Pro
Ile Tyr Ile Tyr
Ile Tyr Leu Tyr
Ile Tyr Tyr Ile
Ile Tyr Tyr Leu
Lys His Met Arg
Lys His Arg Met
Lys His Thr Trp
Lys His Trp Thr
Lys Met His Arg
Lys Met Arg His
Lys Arg His Met
Lys Arg Met His
Lys Thr His Trp
Lys Thr Trp His
Lys Trp His Thr
Lys Trp Thr His
Leu Ile Tyr Tyr
Leu Leu Tyr Tyr
Leu Pro Arg Trp
Leu Pro Trp Arg
Leu Arg Pro Trp
Leu Arg Trp Pro
Leu Trp Pro Arg
Leu Trp Arg Pro
Leu Tyr Ile Tyr
Leu Tyr Leu Tyr
Leu Tyr Tyr Ile
Leu Tyr Tyr Leu
Met His Lys Arg
Met His Arg Lys
Met Lys His Arg
Met Lys Arg His
Met Arg His Lys
Met Arg Lys His
Pro Ile Arg Trp
Pro Ile Trp Arg
Pro Leu Arg Trp
Pro Leu Trp Arg
Pro Arg Ile Trp
Pro Arg Leu Trp
Pro Arg Trp Ile
Pro Arg Trp Leu
Pro Trp Ile Arg
Pro Trp Leu Arg
Pro Trp Arg Ile
Pro Trp Arg Leu
Arg His Lys Met
Arg His Met Lys
Arg Ile Pro Trp
Arg Ile Trp Pro
Arg Lys His Met
Arg Lys Met His
Arg Leu Pro Trp
Arg Leu Trp Pro
Arg Met His Lys
Arg Met Lys His
Arg Pro Ile Trp
Arg Pro Leu Trp
Arg Pro Trp Ile
Arg Pro Trp Leu
Arg Trp Ile Pro
Arg Trp Leu Pro
Arg Trp Pro Ile
Arg Trp Pro Leu
Thr His Lys Trp
Thr His Trp Lys
Thr Lys His Trp
Thr Lys Trp His
Thr Trp His Lys
Thr Trp Lys His
Trp His Lys Thr
Trp His Thr Lys
Trp Ile Pro Arg
Trp Ile Arg Pro
Trp Lys His Thr
Trp Lys Thr His
Trp Leu Pro Arg
Trp Leu Arg Pro
Trp Pro Ile Arg
Trp Pro Leu Arg
Trp Pro Arg Ile
Trp Pro Arg Leu
Trp Arg Ile Pro
Trp Arg Leu Pro
Trp Arg Pro Ile
Trp Arg Pro Leu
Trp Thr His Lys
Trp Thr Lys His
Tyr Ile Ile Tyr
Tyr Ile Leu Tyr
Tyr Ile Tyr Ile
Tyr Ile Tyr Leu
Tyr Leu Ile Tyr
Tyr Leu Leu Tyr
Tyr Leu Tyr Ile
Tyr Leu Tyr Leu
Tyr Tyr Ile Ile
Tyr Tyr Ile Leu
Tyr Tyr Leu Ile
Tyr Tyr Leu Leu
Ganodermic acid P2
Ganoderic acid Mk
3a,15a-Diacetoxy-22R-hydroxylanosta-7,9(11),24-trien-26-Oic acid
2-O-(beta-D-galactopyranosyl-(1->6)-beta-D-galactopyranosyl) 2S,3R-dihydroxytridecanoic acid
N-[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]-4,4-dimethyl-3-oxovaleramide
4-[[1,4-Dimethyl-2-propyl(2,6-bi-1H-benzimidazol)-1-yl]-methyl]-1,1-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester
2,2-Thiobis(4-tert-octylphenolato)-n-butylamine nickel(II)
Olean-12-eno[2,3-c][1,2,5]oxadiazol-28-oic acid phenylmethyl ester
tert-butyl-[(1R,3R)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)cyclohexyl]oxy-dimethylsilane
Titanium, tris2-(2-aminoethyl)aminoethanolato-.kappa.O2,2-bis(2-propenyloxy-.kappa.O)methyl-1-butanolato-.kappa.O-, (OC-6-22)-
2-[3-[3-(5-Carboxypentyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1-propen-1-yl]-3-ethyl-1,1-dimethyl-1H-benz[e]indolium inner salt
BenzeneMethanaMine, α-Methyl-, (R)-, coMpd. with[R-[R*,S*-(E)]]-ethyl7-[2-cyclopropyl-4-(4-fluoro
tert-butyl 2,7-diazaspiro[4.5]decane-2-carboxylate hemioxalate
Dexamethasone cipecilate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(5Z)-5-[(2E,4E,6E,8E)-11-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-2,9-dimethylundeca-2,4,6,8-tetraen-10-ynylidene]-3-[(E)-2-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]ethenyl]furan-2-one
2-[[(2R)-3-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
sodium(2R,3R,Z)-9-(2,5-dihydroxyphenyl)-3,7-dimethyl-1-((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)non-7-en-2-yl sulfate
A natural product found in Coscinoderma species.
sodium(2R,3R,E)-9-(2,5-dihydroxyphenyl)-3,7-dimethyl-1-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)non-7-en-2-yl sulfate
A natural product found in Coscinoderma species.
(2S,4aS,6aS,6bR,10S,12aS,14bR)-10-(3-carboxy-1-oxopropoxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bS)-10-(3-carboxy-1-oxopropoxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
1-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-(1,3-benzodioxol-5-yl)-3-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
N-[(2R,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
1-(1,3-benzodioxol-5-yl)-3-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-(1,3-benzodioxol-5-yl)-3-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
N-[(2S,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
N-[(2S,3R)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
1-(1,3-benzodioxol-5-yl)-3-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-(1,3-benzodioxol-5-yl)-3-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
N-[(2S,3S)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
6-Benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
1-(1,3-benzodioxol-5-yl)-3-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-(1,3-benzodioxol-5-yl)-3-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-(1,3-benzodioxol-5-yl)-3-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
2,3-dihydroxypropyl [2-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propyl] hydrogen phosphate
[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
2-[[(2R)-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-phosphonooxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
2-[[(2R)-3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
3alpha,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11),24-trien-26-oic acid
(1s,3s,9r,11r)-9-benzoyl-4,4,10,10-tetramethyl-3,7,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione
(1s,5r,7r)-5-benzoyl-4-hydroxy-6,6-dimethyl-1-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
13-benzoyl-6,6,8,14,14-pentamethyl-11,15-bis(3-methylbut-2-en-1-yl)-9-oxatetracyclo[11.3.1.0¹,¹⁰.0³,⁸]heptadec-10-ene-12,17-dione
2-[2,5-bis(acetyloxy)-3a,3b,6,9a-tetramethyl-4,7-dioxo-decahydro-2h-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
(2e,5s,6s)-6-[(1s,3s,3as,5as,7r,9ar,11as)-7-(acetyloxy)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid
(2s,3s,4s,5r,6s)-4-ethoxy-2-{[(2r,3s,4s,5r,6s)-2-[(2r)-2-ethoxy-3-methoxypropoxy]-3,5-dimethoxy-6-(methoxymethyl)oxan-4-yl]oxy}-3,5-dimethoxy-6-(methoxymethyl)oxane
(1s,3r,5r,7r,9s,11r)-9-benzoyl-11-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-isopropyl-4,4,8,8-tetramethyltetracyclo[7.3.1.1⁷,¹¹.0¹,⁵]tetradecane-10,12,13-trione
3-{1',3,4,6',6',10',17',21'-octamethyl-5-oxo-14'-oxaspiro[oxolane-2,15'-pentacyclo[11.7.1.0²,¹¹.0⁵,¹⁰.0¹⁸,²¹]henicosan]-2'(11')-en-7'-yloxy}-3-oxopropanoic acid
(5z)-3-[(2r,6s,7ar)-6-hydroxy-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-2-yl]-5-[(2e,4e,6e,8e)-11-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-2,9-dimethylundeca-2,4,6,8-tetraen-10-yn-1-ylidene]furan-2-one
5-[(4e,6e,8e)-11-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-2,9-dimethylundeca-2,4,6,8-tetraen-10-yn-1-ylidene]-3-(6-hydroxy-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-2-yl)furan-2-one
6-[3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-hydroxy-2-methylhept-2-enoic acid
(3s,6s)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-[(2-carboxyacetyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-3-methyl-2-methylidene-4-oxoheptanoic acid
methyl 6-{4,4,8,12,17,17,20-heptamethyl-5,10-dioxo-16,18-dioxapentacyclo[10.6.2.0³,⁸.0⁹,¹⁹.0¹⁵,²⁰]icos-9(19)-en-13-yl}-2-methyl-4-oxoheptanoate
3'-(8,17-epoxy-16-oxo-12,14-labdadien-15-yl)-2',4'-dihydroxy-6'-methoxychalcone
{"Ingredient_id": "HBIN007813","Ingredient_name": "3'-(8,17-epoxy-16-oxo-12,14-labdadien-15-yl)-2',4'-dihydroxy-6'-methoxychalcone","Alias": "NA","Ingredient_formula": "C36H42O6","Ingredient_Smile": "NA","Ingredient_weight": "570.72","OB_score": "NA","CAS_id": "208463-00-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8481","PubChem_id": "NA","DrugBank_id": "NA"}